Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma Foods International CoPMDSF 63 Return-on-Tangible-Asset is 0.82% as of Jan. 2026, which is 87% below its 10-year median of 6.14. GuruFocus rates PMDSF with a GF Score™ of 63/100 and a GF Value™ of $11.44. The stock has 5 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Pharma Foods International Co ranks worse than 70.41% on this metric.
The historical rank and industry rank for Pharma Foods International Co's Return-on-Tangible-Asset or its related term are showing as below:
PMDSF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -3.22 Med: 6.14 Max: 25.06
Current: -3.22
During the past 13 years, Pharma Foods International Co's highest Return-on-Tangible-Asset was 25.06%. The lowest was -3.22%. And the median was 6.14%.
PMDSF's Return-on-Tangible-Asset is ranked worse than 70.41% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 3.16
vs PMDSF: -3.22
Pharma Foods International Co (OTCPK:PMDSF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Pharma Foods International Co Return-on-Tangible-Asset Related Terms
Pharma Foods International Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Foods International Co Return-on-Tangible-Asset Chart
PMDSF vs ZTS, UTHR: Return-on-Tangible-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Foods International Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Foods International Co Return-on-Tangible-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharma Foods International Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Pharma Foods International Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jan. 2026) net income data.
What does a Return-on-Tangible-Asset of 0.82% mean?
Pharma Foods International Co (PMDSF) has a Return-on-Tangible-Asset of 0.82% as of Jan. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Pharma Foods International Co and its competitors. This is 87% below median its historical median of 6.14. According to the industry distribution chart, Pharma Foods International Co ranks #709 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 70.4%.
Is Pharma Foods International Co's Return-on-Tangible-Asset too high?
Pharma Foods International Co's current Return-on-Tangible-Asset of 0.82% is 87% below median its 10-year median of 6.14. The Drug Manufacturers industry median Return-on-Tangible-Asset is 3.16. Pharma Foods International Co's value of 0.82% is 74.1% below this industry median. Based on the distribution chart, Pharma Foods International Co ranks #709 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Pharma Foods International Co has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Pharma Foods International Co's Return-on-Tangible-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Pharma Foods International Co ranks #709 out of 1007 companies for Return-on-Tangible-Asset. This places Pharma Foods International Co in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.16. Pharma Foods International Co's value of 0.82% is 74.1% below this benchmark. While the company's 10-year median is 6.14 vs. the industry median of 3.16, Pharma Foods International Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Drug Manufacturers company?
The median Return-on-Tangible-Asset among Drug Manufacturers companies is 3.16, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma Foods International Co's current Return-on-Tangible-Asset of 0.82% is 74.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Pharma Foods International Co and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Asset is 3.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Foods International Co's current Return-on-Tangible-Asset is 0.82%, which is 87% below median its own 10-year median of 6.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Foods International Co stock overvalued right now?
Pharma Foods International Co (PMDSF) has a current Return-on-Tangible-Asset of 0.82%. The stock's GF Value™ is $11.44, compared to a current price of $6.40 — trading 44.1% below its estimated fair value. The current Return-on-Tangible-Asset is 0.82%, which is 87% below median its 10-year median of 6.14 and 74.1% below the Drug Manufacturers industry median of 3.16. Pharma Foods International Co's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Pharma Foods International Co (PMDSF), the current Return-on-Tangible-Asset is 0.82% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma Foods International Co (PMDSF) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma Foods International Co stock appears to be undervalued.
The current stock price of $6.40 is trading 44.1% below its estimated GF Value™ of $11.44.
Key valuation signals for PMDSF:
Return-on-Tangible-Asset: 0.82% (87% below median its 10-year median of 6.14)
GF Value™: $11.44 vs. price of $6.40 (44.1% below fair value)
Industry Position: 74.1% below the Drug Manufacturers median (#709 of 1007)
No single metric tells the full story. See the PMDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma Foods International Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMDSF has been successfully added to your 
